Choose smart money in health 4 reasons to raise funds with Angels Santé 1 Access our 150+ expert healthcare investors 2 Connect to our French and European healthcare ecosystem 3 Get active support throughout your business development 2 Connect to our French and European healthcare ecosystem 4 Become an exclusive member of the Angels Santé Family How to be selected ? You are a French healthcare start-up (pas de Wellness , Foodtech). Votre équipe est si possible complémentaire (scientifique/business). Vous avez déjà levé en non dilutif ( quand le secteur le permet) Vous levez votre premier véritable tour de dilutif de minimum 400 K€ Votre valo pré-money n'excéde pas les 5 m€. Your closing date is au moins 6 mois et votre cash burn permet de tenir 6 mois voire idéalement 12 mois . You have at least one POC (proof of concept). Depending on your sector Biotech : votre PoC est au stade pré-clinique invivo/résultats chez le petit animalMedtech : prototype fonctionnel avec essai probantDigital Health: votre solution est développée et présente un début de traction (commerciale, pilote, partenariat)Tick all the boxes ?Let's check your eligibility. Submit your application Télécharger la brochure candidat important to know The Angels Santé fundraising process takes an average of 3 to 6 months from application to closing. Before applying, make sure you can anticipate this timeframe. Our selection process Pre-application Submit your application on our Dealum platform 1 1 day Pre-application eligibility check According to our investment thesis 2 2 weeks Selection committee A one-hour meeting before validation to pitch 3 4 to 6 weeks/1 to 1.5 month Pitch to our investors *210 € participation fee per company 4 8 to 12 weeks/ 2 to 3 months Due Diligence ( HR, IP, finance, contracts, négociation …) 5 4 weeks1 month Closing pitch and investment *4.5% Success fee 6 Discover our Portfolio Companies biotech HuntX Pharma , 2024 - Grenoble HuntX Pharma développe de petites molécules orales pour prévenir l’apparition de maladies neurodégénératives génétiques. medtech Winnove , 2024 - Rennes Winnove amélioree l’efficacité thérapeutique de la contention orthodontique et garantit le sourire de 34 millions de patients biotech Hephaistos Pharma , 2023 - Paris Hephaistos-Pharma is developing a new generation of immunostimulant to treat metastatic and hardly accessible tumors biotech Alga Therapeutics , 2023 - Rouen Alga Therpeutics produces cancer-fighting antibodies from micro-algae. biotech Abcely , 2023 - Nantes Abcely develops innovative medical and pharmaceutical technologies for the treatment of mucosal cancers. medtech Bliss TX , 2023 - Laval A new generation of digital solutions for pain management throughout the patient journey. See all our invested companies